Follow
Jiachen Yang
Jiachen Yang
PhD Student, Osaka University
Verified email at ist.osaka-u.ac.jp - Homepage
Title
Cited by
Cited by
Year
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
N Afdhal, S Zeuzem, P Kwo, M Chojkier, N Gitlin, M Puoti, ...
New England Journal of Medicine 370 (20), 1889-1898, 2014
21902014
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
L Paz-Ares, EH Tan, K O’Byrne, L Zhang, V Hirsh, M Boyer, JCH Yang, ...
Annals of Oncology 28 (2), 270-277, 2017
5952017
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally …
D Miles, J Gligorov, F André, D Cameron, A Schneeweiss, C Barrios, B Xu, ...
Annals of Oncology 32 (8), 994-1004, 2021
5432021
Pemetrexed plus platinum with or without pembrolizumab in patients with previously untreated metastatic nonsquamous NSCLC: protocol-specified final analysis from KEYNOTE-189
D Rodríguez-Abreu, SF Powell, MJ Hochmair, S Gadgeel, E Esteban, ...
Annals of Oncology 32 (7), 881-895, 2021
4312021
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
GR Oxnard, JCH Yang, H Yu, SW Kim, H Saka, L Horn, K Goto, Y Ohe, ...
Annals of Oncology 31 (4), 507-516, 2020
3822020
Overview of current systemic management of EGFR-mutant NSCLC
WH Hsu, JCH Yang, TS Mok, HH Loong
Annals of Oncology 29, i3-i9, 2018
3612018
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
G Curigliano, S Banerjee, A Cervantes, MC Garassino, P Garrido, ...
Annals of Oncology 31 (10), 1320-1335, 2020
3422020
& Yuen, KY (2020). A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
JFW Chan, S Yuan, KH Kok, KKW To, H Chu, J Yang, F Xing, J Liu, ...
The lancet 395 (10223), 514-523, 0
308
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO–ESMO initiative endorsed by JSMO, KSMO, MOS …
YL Wu, D Planchard, S Lu, H Sun, N Yamamoto, DW Kim, DSW Tan, ...
Annals of Oncology 30 (2), 171-210, 2019
3062019
Net global warming potential and greenhouse gas intensity of annual rice–wheat rotations with integrated soil–crop system management
YC Ma, XW Kong, B Yang, XL Zhang, XY Yan, JC Yang, ZQ Xiong
Agriculture, ecosystems & environment 164, 209-219, 2013
2752013
Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study
VA Papadimitrakopoulou, YL Wu, JY Han, MJ Ahn, SS Ramalingam, ...
Annals of Oncology 29, viii741, 2018
2702018
Effects of external phosphorus on the cell ultrastructure and the chlorophyll content of maize under cadmium and zinc stress
HM Jiang, JC Yang, JF Zhang
Environmental pollution 147 (3), 750-756, 2007
2342007
CNS response to osimertinib in patients with T790M-positive advanced NSCLC: pooled data from two phase II trials
G Goss, CM Tsai, FA Shepherd, MJ Ahn, L Bazhenova, L Crinò, ...
Annals of Oncology 29 (3), 687-693, 2018
2232018
Effect of dose adjustment on the safety and efficacy of afatinib for EGFR mutation-positive lung adenocarcinoma: post hoc analyses of the randomized LUX-Lung 3 and 6 trials
JCH Yang, LV Sequist, C Zhou, M Schuler, SL Geater, T Mok, CP Hu, ...
Annals of Oncology 27 (11), 2103-2110, 2016
2032016
MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene
J Yang, Z Zhang, C Chen, Y Liu, Q Si, TH Chuang, N Li, ...
Oncogene 33 (23), 3014-3023, 2014
1932014
Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial
M Schuler, JCH Yang, K Park, JH Kim, J Bennouna, YM Chen, C Chouaid, ...
Annals of Oncology 27 (3), 417-423, 2016
1662016
Effect of microvoids on initial and light‐degraded efficiencies of hydrogenated amorphous silicon alloy solar cells
S Guha, J Yang, SJ Jones, Y Chen, DL Williamson
Applied physics letters 61 (12), 1444-1446, 1992
1461992
KEYNOTE-021 investigators. Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the …
CJ Langer, SM Gadgeel, H Borghaei, VA Papadimitrakopoulou, A Patnaik, ...
Lancet Oncol 17 (11), 1497-1508, 2016
1402016
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition
HQ Ju, G Zhan, A Huang, Y Sun, S Wen, J Yang, WH Lu, RH Xu, J Li, Y Li, ...
Leukemia 31 (10), 2143-2150, 2017
1292017
Safety, efficacy, and pharmacokinetics of almonertinib (HS-10296) in pretreated patients with EGFR-mutated advanced NSCLC: a multicenter, open-label, phase 1 trial
JCH Yang, DR Camidge, CT Yang, J Zhou, R Guo, CH Chiu, GC Chang, ...
Journal of Thoracic Oncology 15 (12), 1907-1918, 2020
1272020
The system can't perform the operation now. Try again later.
Articles 1–20